Price Chart

Key Stats

Net Expense Ratio Discount or Premium to NAV Total Assets Under Management 30-Day Average Daily Volume
0.65% 0.07% 8.841M 722.43
Weighted Average Dividend Yield Turnover Ratio (Generic) 1 Year Fund Level Flows Max Drawdown (Since Inception)
1.33% 55.00% -154189.0

Basic Info

Investment Strategy
The Fund seeks to provide long-term capital appreciation. Under normal circumstances, the Fund will primarily invest in the equity securities of Healthcare Companies which the adviser believes are leaders and where the magnitude and/or duration of future growth for these companies is underappreciated by the market.
General
Security Type Exchange-Traded Fund
Equity Style Large Cap Core
Broad Asset Class Sector Equity
Broad Category Equity
Global Peer Group Equity Sector Healthcare
Peer Group Global Health/Biotechnology Funds
Global Macro Equity Industry Sector
US Macro World Sector Equity Funds
YCharts Categorization --
YCharts Benchmark --
Prospectus Objective Global Health/Biotechnology Funds
Fund Owner Firm Name J.P. Morgan Asset Management
Broad Asset Class Benchmark Index
^MSWNTR 100.0%

View Basic Info
Start Trial

Performance Versus Peer Group

 
20%
15%
10%
5%
0
View Category Returns. Upgrade now.
Name
1M
3M
YTD
1Y
3Y
5Y
10Y
15Y
Total Return (Price)
--
--
--
--
--
--
--
--
Total Return (NAV)
--
--
--
--
--
--
--
--
Peer Group Rtn. (NAV)
--
--
--
--
--
--
--
--
% Rank in Peer Group (NAV)
--
--
--
--
--
--
--
--

Annual Total Returns Versus Peers

Loading chart...
Name
2019
2020
2021
2022
2023
2024
2025
YTD
--
--
--
--
--
-1.01%
15.38%
1.96%
27.67%
15.90%
21.82%
-18.14%
23.79%
18.67%
21.09%
2.32%
23.22%
12.75%
19.59%
-4.93%
3.64%
0.55%
15.00%
3.46%
--
--
-3.96%
-19.69%
5.70%
1.55%
21.79%
1.76%
19.40%
5.51%
17.79%
2.62%
6.95%
8.06%
21.98%
7.54%
--
--
--
--
-5.41%
-4.66%
28.62%
4.90%
As of February 20, 2026.

Asset Allocation

As of January 31, 2026.
Type % Net
Cash 0.77%
Stock 98.19%
Bond 0.00%
Convertible 0.00%
Preferred 1.04%
Other 0.00%
View Asset Allocation
Start Trial

Basic Info

Investment Strategy
The Fund seeks to provide long-term capital appreciation. Under normal circumstances, the Fund will primarily invest in the equity securities of Healthcare Companies which the adviser believes are leaders and where the magnitude and/or duration of future growth for these companies is underappreciated by the market.
General
Security Type Exchange-Traded Fund
Equity Style Large Cap Core
Broad Asset Class Sector Equity
Broad Category Equity
Global Peer Group Equity Sector Healthcare
Peer Group Global Health/Biotechnology Funds
Global Macro Equity Industry Sector
US Macro World Sector Equity Funds
YCharts Categorization --
YCharts Benchmark --
Prospectus Objective Global Health/Biotechnology Funds
Fund Owner Firm Name J.P. Morgan Asset Management
Broad Asset Class Benchmark Index
^MSWNTR 100.0%

View Basic Info
Start Trial

Top Portfolio Holders